Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid.

Clark LR, Berman SE, Norton D, Koscik RL, Jonaitis E, Blennow K, Bendlin BB, Asthana S, Johnson SC, Zetterberg H, Carlsson CM.

Neurology. 2018 Apr 10;90(15):e1306-e1315. doi: 10.1212/WNL.0000000000005291. Epub 2018 Mar 9.

PMID:
29523644
2.

Cognitive decline in the middle-aged after surgery and anaesthesia: results from the Wisconsin Registry for Alzheimer's Prevention cohort.

Bratzke LC, Koscik RL, Schenning KJ, Clark LR, Sager MA, Johnson SC, Hermann BP, Hogan KJ.

Anaesthesia. 2018 May;73(5):549-555. doi: 10.1111/anae.14216. Epub 2018 Feb 21.

PMID:
29468634
3.

The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions.

Johnson SC, Koscik RL, Jonaitis EM, Clark LR, Mueller KD, Berman SE, Bendlin BB, Engelman CD, Okonkwo OC, Hogan KJ, Asthana S, Carlsson CM, Hermann BP, Sager MA.

Alzheimers Dement (Amst). 2017 Dec 8;10:130-142. doi: 10.1016/j.dadm.2017.11.007. eCollection 2018. Review.

4.

The Latent Structure and Test-Retest Stability of Connected Language Measures in the Wisconsin Registry for Alzheimer's Prevention (WRAP).

Mueller KD, Koscik RL, Clark LR, Hermann BP, Johnson SC, Turkstra LS.

Arch Clin Neuropsychol. 2017 Nov 24:1-13. doi: 10.1093/arclin/acx116. [Epub ahead of print]

PMID:
29186313
5.

Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.

Berman SE, Clark LR, Rivera-Rivera LA, Norton D, Racine AM, Rowley HA, Bendlin BB, Blennow K, Zetterberg H, Carlsson CM, Asthana S, Turski P, Wieben O, Johnson SC.

J Alzheimers Dis. 2017;60(1):243-252. doi: 10.3233/JAD-170402.

6.

Use of the Quick Dementia Rating System (QDRS) as an Initial Screening Measure in a Longitudinal Cohort at Risk for Alzheimer's Disease.

Berman SE, Koscik RL, Clark LR, Mueller KD, Bluder L, Galvin JE, Johnson SC.

J Alzheimers Dis Rep. 2017;1(1):9-13. doi: 10.3233/ADR-170004. Epub 2017 Apr 28.

7.

Longitudinal Assessment of Self- and Informant-Subjective Cognitive Complaints in a Sample of Healthy Late-Middle Aged Adults Enriched with a Family History of Alzheimer's Disease.

Nicholas CR, Dowling NM, Racine AM, Clark LR, Berman SE, Koscik RL, Asthana S, Hermann B, Sager MA, Johnson SC.

J Int Neuropsychol Soc. 2017 Sep;23(8):617-626. doi: 10.1017/S1355617717000509. Epub 2017 Jul 11.

PMID:
28693655
8.

Faulty Adaptation to Repeated Face-Name Associative Pairs in Mild Cognitive Impairment is Predictive of Cognitive Decline.

Jurick SM, Weissberger GH, Clark LR, Wierenga CE, Chang YL, Schiehser DM, Han SD, Jak AJ, Dev SI, Bondi MW.

Arch Clin Neuropsychol. 2018 Mar 1;33(2):168-183. doi: 10.1093/arclin/acx056.

PMID:
28655152
9.

A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium.

Gross AL, Hassenstab JJ, Johnson SC, Clark LR, Resnick SM, Kitner-Triolo M, Masters CL, Maruff P, Morris JC, Soldan A, Pettigrew C, Albert MS.

Alzheimers Dement (Amst). 2017 May 30;8:147-155. doi: 10.1016/j.dadm.2017.05.003. eCollection 2017.

10.

Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults.

Racine AM, Merluzzi AP, Adluru N, Norton D, Koscik RL, Clark LR, Berman SE, Nicholas CR, Asthana S, Alexander AL, Blennow K, Zetterberg H, Kim WH, Singh V, Carlsson CM, Bendlin BB, Johnson SC.

Brain Imaging Behav. 2017 Jun 9. doi: 10.1007/s11682-017-9732-9. [Epub ahead of print]

PMID:
28600739
11.

BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention.

Boots EA, Schultz SA, Clark LR, Racine AM, Darst BF, Koscik RL, Carlsson CM, Gallagher CL, Hogan KJ, Bendlin BB, Asthana S, Sager MA, Hermann BP, Christian BT, Dubal DB, Engelman CD, Johnson SC, Okonkwo OC.

Neurology. 2017 May 30;88(22):2098-2106. doi: 10.1212/WNL.0000000000003980. Epub 2017 May 3.

12.

Positive affect predicts cerebral glucose metabolism in late middle-aged adults.

Nicholas CR, Hoscheidt SM, Clark LR, Racine AM, Berman SE, Koscik RL, Maritza Dowling N, Asthana S, Christian BT, Sager MA, Johnson SC.

Soc Cogn Affect Neurosci. 2017 Jun 1;12(6):993-1000. doi: 10.1093/scan/nsx027.

13.

Accelerated and accentuated neurocognitive aging in HIV infection.

Sheppard DP, Iudicello JE, Morgan EE, Kamat R, Clark LR, Avci G, Bondi MW, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

J Neurovirol. 2017 Jun;23(3):492-500. doi: 10.1007/s13365-017-0523-2. Epub 2017 Mar 20.

14.

Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease.

Clark LR, Berman SE, Rivera-Rivera LA, Hoscheidt SM, Darst BF, Engelman CD, Rowley HA, Carlsson CM, Asthana S, Turski P, Wieben O, Johnson SC.

Alzheimers Dement (Amst). 2017 Jan 23;7:48-55. doi: 10.1016/j.dadm.2017.01.002. eCollection 2017.

15.

Intraindividual Cognitive Variability in Middle Age Predicts Cognitive Impairment 8-10 Years Later: Results from the Wisconsin Registry for Alzheimer's Prevention.

Koscik RL, Berman SE, Clark LR, Mueller KD, Okonkwo OC, Gleason CE, Hermann BP, Sager MA, Johnson SC.

J Int Neuropsychol Soc. 2016 Nov;22(10):1016-1025.

16.

Connected Language in Late Middle-Aged Adults at Risk for Alzheimer's Disease.

Mueller KD, Koscik RL, Turkstra LS, Riedeman SK, LaRue A, Clark LR, Hermann B, Sager MA, Johnson SC.

J Alzheimers Dis. 2016 Oct 18;54(4):1539-1550.

17.

Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.

Racine AM, Clark LR, Berman SE, Koscik RL, Mueller KD, Norton D, Nicholas CR, Blennow K, Zetterberg H, Jedynak B, Bilgel M, Carlsson CM, Christian BT, Asthana S, Johnson SC.

J Alzheimers Dis. 2016 Oct 18;54(4):1395-1408.

18.

Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.

Racine AM, Koscik RL, Berman SE, Nicholas CR, Clark LR, Okonkwo OC, Rowley HA, Asthana S, Bendlin BB, Blennow K, Zetterberg H, Gleason CE, Carlsson CM, Johnson SC.

Brain. 2016 Aug;139(Pt 8):2261-74. doi: 10.1093/brain/aww142. Epub 2016 Jun 20.

19.

Mild Cognitive Impairment in Late Middle Age in the Wisconsin Registry for Alzheimer's Prevention Study: Prevalence and Characteristics Using Robust and Standard Neuropsychological Normative Data.

Clark LR, Koscik RL, Nicholas CR, Okonkwo OC, Engelman CD, Bratzke LC, Hogan KJ, Mueller KD, Bendlin BB, Carlsson CM, Asthana S, Sager MA, Hermann BP, Johnson SC.

Arch Clin Neuropsychol. 2016 May 8. pii: acw024. [Epub ahead of print]

20.

Cerebrospinal fluid ratios with Aβ42 predict preclinical brain β-amyloid accumulation.

Racine AM, Koscik RL, Nicholas CR, Clark LR, Okonkwo OC, Oh JM, Hillmer AT, Murali D, Barnhart TE, Betthauser TJ, Gallagher CL, Rowley HA, Dowling NM, Asthana S, Bendlin BB, Blennow K, Zetterberg H, Carlsson CM, Christian BT, Johnson SC.

Alzheimers Dement (Amst). 2016;2:27-38.

21.

Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.

Clark LR, Racine AM, Koscik RL, Okonkwo OC, Engelman CD, Carlsson CM, Asthana S, Bendlin BB, Chappell R, Nicholas CR, Rowley HA, Oh JM, Hermann BP, Sager MA, Christian BT, Johnson SC.

Alzheimers Dement. 2016 Jul;12(7):805-14. doi: 10.1016/j.jalz.2015.12.009. Epub 2016 Jan 21.

22.

Intracranial Arterial 4D-Flow is Associated with Metrics of Brain Health and Alzheimer's Disease.

Berman SE, Rivera-Rivera LA, Clark LR, Racine AM, Keevil JG, Bratzke LC, Carlsson CM, Bendlin BB, Rowley HA, Blennow K, Zetterberg H, Asthana S, Turski P, Johnson SC, Wieben O.

Alzheimers Dement (Amst). 2015 Dec 1;1(4):420-428.

23.

Verbal Fluency and Early Memory Decline: Results from the Wisconsin Registry for Alzheimer's Prevention.

Mueller KD, Koscik RL, LaRue A, Clark LR, Hermann B, Johnson SC, Sager MA.

Arch Clin Neuropsychol. 2015 Aug;30(5):448-57. doi: 10.1093/arclin/acv030. Epub 2015 May 29.

24.

Elevated cerebrovascular resistance index is associated with cognitive dysfunction in the very-old.

Clark LR, Nation DA, Wierenga CE, Bangen KJ, Dev SI, Shin DD, Delano-Wood L, Liu TT, Rissman RA, Bondi MW.

Alzheimers Res Ther. 2015 Jan 21;7(1):3. doi: 10.1186/s13195-014-0080-3.

25.

Language and task switching in the bilingual brain: Bilinguals are staying, not switching, experts.

Weissberger GH, Gollan TH, Bondi MW, Clark LR, Wierenga CE.

Neuropsychologia. 2015 Jan;66:193-203. doi: 10.1016/j.neuropsychologia.2014.10.037. Epub 2014 Nov 14.

26.

Interactive effects of vascular risk burden and advanced age on cerebral blood flow.

Bangen KJ, Nation DA, Clark LR, Harmell AL, Wierenga CE, Dev SI, Delano-Wood L, Zlatar ZZ, Salmon DP, Liu TT, Bondi MW.

Front Aging Neurosci. 2014 Jul 7;6:159. doi: 10.3389/fnagi.2014.00159. eCollection 2014.

27.

Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Edmonds EC, Delano-Wood L, Clark LR, Jak AJ, Nation DA, McDonald CR, Libon DJ, Au R, Galasko D, Salmon DP, Bondi MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2015 Apr;11(4):415-24. doi: 10.1016/j.jalz.2014.03.005. Epub 2014 May 22.

28.

Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.

Bondi MW, Edmonds EC, Jak AJ, Clark LR, Delano-Wood L, McDonald CR, Nation DA, Libon DJ, Au R, Galasko D, Salmon DP.

J Alzheimers Dis. 2014;42(1):275-89. doi: 10.3233/JAD-140276.

29.

Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease.

Nation DA, Wierenga CE, Clark LR, Dev SI, Stricker NH, Jak AJ, Salmon DP, Delano-Wood L, Bangen KJ, Rissman RA, Liu TT, Bondi MW.

J Alzheimers Dis. 2013;36(4):689-98. doi: 10.3233/JAD-130086.

30.

Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes?

Clark LR, Delano-Wood L, Libon DJ, McDonald CR, Nation DA, Bangen KJ, Jak AJ, Au R, Salmon DP, Bondi MW.

J Int Neuropsychol Soc. 2013 Jul;19(6):635-45. doi: 10.1017/S1355617713000313. Epub 2013 Apr 3.

31.

Interaction of age and APOE genotype on cerebral blood flow at rest.

Wierenga CE, Clark LR, Dev SI, Shin DD, Jurick SM, Rissman RA, Liu TT, Bondi MW.

J Alzheimers Dis. 2013;34(4):921-35. doi: 10.3233/JAD-121897.

32.

Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black women.

Clark LR, Myers ER, Huh W, Joura EA, Paavonen J, Perez G, James MK, Sings HL, Haupt RM, Saah AJ, Garner EI.

J Adolesc Health. 2013 Mar;52(3):322-9. doi: 10.1016/j.jadohealth.2012.07.003. Epub 2012 Aug 15.

PMID:
23299013
33.

Yes/no versus forced-choice recognition memory in mild cognitive impairment and Alzheimer's disease: patterns of impairment and associations with dementia severity.

Clark LR, Stricker NH, Libon DJ, Delano-Wood L, Salmon DP, Delis DC, Bondi MW.

Clin Neuropsychol. 2012;26(7):1201-16. doi: 10.1080/13854046.2012.728626. Epub 2012 Oct 2.

34.

Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition.

Wierenga CE, Dev SI, Shin DD, Clark LR, Bangen KJ, Jak AJ, Rissman RA, Liu TT, Salmon DP, Bondi MW.

J Cereb Blood Flow Metab. 2012 Aug;32(8):1589-99. doi: 10.1038/jcbfm.2012.58. Epub 2012 May 2.

35.

Specific measures of executive function predict cognitive decline in older adults.

Clark LR, Schiehser DM, Weissberger GH, Salmon DP, Delis DC, Bondi MW.

J Int Neuropsychol Soc. 2012 Jan;18(1):118-27. doi: 10.1017/S1355617711001524. Epub 2011 Nov 24.

36.

Menstrual irregularity from hormonal contraception: a cause of reproductive health concerns in minority adolescent young women.

Clark LR, Barnes-Harper KT, Ginsburg KR, Holmes WC, Schwarz DF.

Contraception. 2006 Sep;74(3):214-9. Epub 2006 May 19.

PMID:
16904414
37.

Group B streptococcal vaginitis in postpubertal adolescent girls.

Clark LR, Atendido M.

J Adolesc Health. 2005 May;36(5):437-40.

PMID:
15837348
38.

Fitz-Hugh-Curtis syndrome: a diagnosis to consider in women with right upper quadrant pain.

Peter NG, Clark LR, Jaeger JR.

Cleve Clin J Med. 2004 Mar;71(3):233-9. Review.

PMID:
15055246
39.

Approaching the adolescent patient from a psychodevelopmental framework.

Clark LR.

J Pediatr Adolesc Gynecol. 2003 Oct;16(5):327-30. No abstract available.

PMID:
14597024
40.

Adolescent knowledge about sexually transmitted diseases.

Clark LR, Jackson M, Allen-Taylor L.

Sex Transm Dis. 2002 Aug;29(8):436-43.

PMID:
12172527
42.

How do we get back our humanity?

Clark LR.

Med Econ. 2001 May 7;78(9):96-8. No abstract available.

PMID:
11383419
43.

Commentary: lessons from a teendoc: the joys and challenges of adolescent medicine.

Clark LR.

J Pediatr Psychol. 1998 Dec;23(6):389-91. No abstract available.

PMID:
9824927
44.

Effect of HIV counseling and testing on sexually transmitted diseases and condom use in an urban adolescent population.

Clark LR, Brasseux C, Richmond D, Getson P, D'Angelo LJ.

Arch Pediatr Adolesc Med. 1998 Mar;152(3):269-73.

PMID:
9529465
45.

Are adolescents accurate in self-report of frequencies of sexually transmitted diseases and pregnancies?

Clark LR, Brasseux C, Richmond D, Getson P, D'Angelo LJ.

J Adolesc Health. 1997 Aug;21(2):91-6.

PMID:
9248933
46.

Alternative nursing environments: do they affect hospital outcomes?

Clark LR, Fraaza V, Schroeder S, Maddens ME.

J Gerontol Nurs. 1995 Nov;21(11):32-8.

PMID:
7594255
47.

A piece of my mind. Teen sex blues.

Clark LR.

JAMA. 1995 Jun 28;273(24):1969-70. No abstract available.

PMID:
7783311
48.

1993 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Litovitz TL, Clark LR, Soloway RA.

Am J Emerg Med. 1994 Sep;12(5):546-84. No abstract available.

PMID:
8060411
49.

A piece of my mind. Joshua knew.

Clark LR.

JAMA. 1993 Dec 22-29;270(24):2902. No abstract available.

PMID:
8254837
50.

1992 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Litovitz TL, Holm KC, Clancy C, Schmitz BF, Clark LR, Oderda GM.

Am J Emerg Med. 1993 Sep;11(5):494-555. Review. No abstract available.

PMID:
8103331

Supplemental Content

Loading ...
Support Center